ADMA Biologics will join the S&P SmallCap 600 index, effective prior to the open of trading on Monday, September 23, 2024. The S&P SmallCap 600 seeks to measure the small-cap segment of the U.S. equity market.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADMA:
- ADMA Biologics Set to Join S&P SmallCap 600 Index
- Biotech Alert: Searches spiking for these stocks today
- ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
- S&P announces changes to S&P 400, 600 indexes for quarterly rebalance
- Largest borrow rate increases among liquid names